Evaluation of ventricular wall stress and cardiac function in patients with dilated cardiomyopathy

Francesco Scardulla1, Antonino Rinaudo1, Salvatore Pasta2

  • 1DICGIM, Università degli Studi di Palermo, Palermo, Italy.

Insights

Dilated cardiomyopathy significantly increases left ventricular wall stress and reduces heart pump function. Patient-specific finite element analysis reveals this cardiac remodeling contributes to heart failure progression.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Computational Mechanics

Background:

  • Dilated cardiomyopathy (DCM) is a severe heart condition marked by left ventricular enlargement and impaired systolic function.
  • This leads to cardiac remodeling, heart failure, and poor clinical outcomes.
  • Understanding the mechanical changes in DCM is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the impact of dilated cardiomyopathy on cardiac pump performance.
  • To analyze myocardial wall mechanics in DCM patients using patient-specific computational models.
  • To correlate mechanical changes with disease progression and clinical course.

Main Methods:

  • Utilized patient-specific finite element analysis (FEA) to model the left ventricle.
  • Quantified end-systolic wall stress and pressure-volume relationships.
  • Compared mechanical parameters between DCM patients and healthy controls.

Main Results:

  • Patients with DCM exhibited significantly higher end-systolic wall stress compared to controls.
  • Both ventricles in DCM patients showed rightward shifts in pressure-volume relationships, indicating reduced contractility.
  • FEA provided detailed insights into mechanical dysfunction in DCM.

Conclusions:

  • Finite element analysis is a valuable tool for assessing myocardial wall stress and cardiac workload in DCM.
  • Elevated wall stress and reduced contractility are key mechanical factors driving left ventricular deterioration in DCM.
  • These findings support the use of FEA for predicting clinical outcomes in dilated cardiomyopathy.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
751
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.4K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
634
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
697
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
443
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
809